This brand name is authorized in Israel
The drug PREVENAR 20 contains a combination of these active pharmaceutical ingredients (APIs):
1
Pneumococcus antigen, serotype 1
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
2
Pneumococcus antigen, serotype 3
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
3
Pneumococcus antigen, serotype 4
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
4
Pneumococcus antigen, serotype 5
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
5
Pneumococcus antigen, serotype 6A
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
6
Pneumococcus antigen, serotype 6B
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
7
Pneumococcus antigen, serotype 7F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
8
Pneumococcus antigen, serotype 8
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
9
Pneumococcus antigen, serotype 9V
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
10
Pneumococcus antigen, serotype 10A
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
11
Pneumococcus antigen, serotype 11A
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
12
Pneumococcus antigen, serotype 12F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
13
Pneumococcus antigen, serotype 14
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
14
Pneumococcus antigen, serotype 15b
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
15
Pneumococcus antigen, serotype 18C
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
16
Pneumococcus antigen, serotype 19A
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
17
Pneumococcus antigen, serotype 19F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
18
Pneumococcus antigen, serotype 22F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
19
Pneumococcus antigen, serotype 23F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
20
Pneumococcus antigen, serotype 33F
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J07AL02 | Pneumococcus, purified polysaccharides antigen conjugated | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9324 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.